LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Fedratinib | 0.12 | uM | LJP5 | 3 | L05 | 72 | hr | 658 | 3625 | 3938 | 0.9204 | 0.9368 |
Hs 578T | Fedratinib | 0.37 | uM | LJP5 | 1 | L04 | 72 | hr | 658 | 3298 | 3908 | 0.8438 | 0.8721 |
Hs 578T | Fedratinib | 0.37 | uM | LJP5 | 2 | L04 | 72 | hr | 658 | 3230 | 3953 | 0.8170 | 0.8496 |
Hs 578T | Fedratinib | 0.37 | uM | LJP5 | 3 | L04 | 72 | hr | 658 | 3147 | 3938 | 0.7991 | 0.8335 |
Hs 578T | Fedratinib | 1.11 | uM | LJP5 | 1 | L03 | 72 | hr | 658 | 2222 | 3908 | 0.5685 | 0.6055 |
Hs 578T | Fedratinib | 1.11 | uM | LJP5 | 2 | L03 | 72 | hr | 658 | 2275 | 3953 | 0.5754 | 0.6152 |
Hs 578T | Fedratinib | 1.11 | uM | LJP5 | 3 | L03 | 72 | hr | 658 | 1996 | 3938 | 0.5068 | 0.5370 |
Hs 578T | Fedratinib | 3.33 | uM | LJP5 | 1 | L02 | 72 | hr | 658 | 1231 | 3908 | 0.3150 | 0.2759 |
Hs 578T | Fedratinib | 3.33 | uM | LJP5 | 2 | L02 | 72 | hr | 658 | 1264 | 3953 | 0.3197 | 0.2870 |
Hs 578T | Fedratinib | 3.33 | uM | LJP5 | 3 | L02 | 72 | hr | 658 | 1315 | 3938 | 0.3339 | 0.3075 |
Hs 578T | Fedratinib | 10 | uM | LJP5 | 1 | L01 | 72 | hr | 658 | 352 | 3908 | 0.0901 | -0.2161 |
Hs 578T | Fedratinib | 10 | uM | LJP5 | 2 | L01 | 72 | hr | 658 | 419 | 3953 | 0.1060 | -0.1602 |
Hs 578T | Fedratinib | 10 | uM | LJP5 | 3 | L01 | 72 | hr | 658 | 349 | 3938 | 0.0886 | -0.2179 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 658 | 1127 | 3908 | 0.2884 | 0.2328 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 658 | 1050 | 3953 | 0.2656 | 0.1979 |
Hs 578T | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 658 | 1140 | 3938 | 0.2895 | 0.2372 |
Hs 578T | Trametinib | 0.12 | uM | LJP5 | 1 | P23 | 72 | hr | 658 | 942 | 3908 | 0.2410 | 0.1497 |
Hs 578T | Trametinib | 0.12 | uM | LJP5 | 2 | P23 | 72 | hr | 658 | 880 | 3953 | 0.2226 | 0.1188 |
Hs 578T | Trametinib | 0.12 | uM | LJP5 | 3 | P23 | 72 | hr | 658 | 1045 | 3938 | 0.2653 | 0.1962 |
Hs 578T | Trametinib | 0.37 | uM | LJP5 | 1 | P22 | 72 | hr | 658 | 905 | 3908 | 0.2316 | 0.1319 |
Hs 578T | Trametinib | 0.37 | uM | LJP5 | 2 | P22 | 72 | hr | 658 | 818 | 3953 | 0.2069 | 0.0877 |
Hs 578T | Trametinib | 0.37 | uM | LJP5 | 3 | P22 | 72 | hr | 658 | 950 | 3938 | 0.2412 | 0.1528 |
Hs 578T | Trametinib | 1.11 | uM | LJP5 | 1 | P21 | 72 | hr | 658 | 948 | 3908 | 0.2426 | 0.1525 |
Hs 578T | Trametinib | 1.11 | uM | LJP5 | 2 | P21 | 72 | hr | 658 | 853 | 3953 | 0.2158 | 0.1054 |
Hs 578T | Trametinib | 1.11 | uM | LJP5 | 3 | P21 | 72 | hr | 658 | 995 | 3938 | 0.2526 | 0.1736 |